Symbols / LIPO $0.05 +0.00% Lipella Pharmaceuticals Inc.

Healthcare • Biotechnology • United States • PNK
LIPO Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country PNK · United States
Market Cap 231.04K
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand —
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close $0.05
Price $0.05
Change 0.00%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest LIPO news

No recent news from Yahoo. Try the RSS feed for latest LIPO news.

Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.54
+19.29%
0.45
+144.15%
0.18
-28.99%
0.26
Operating Revenue
0.54
+19.29%
0.45
0.00
0.00
Cost Of Revenue
3.61
+18.90%
3.04
+19.28%
2.55
+74.88%
1.46
Reconciled Cost Of Revenue
3.61
+18.90%
3.04
+19.28%
2.55
+74.88%
1.46
Gross Profit
-3.08
-18.83%
-2.59
-9.55%
-2.36
-97.38%
-1.20
Operating Expense
2.00
-7.10%
2.16
+853.50%
0.23
-68.51%
0.72
Research And Development
—
—
2.55
+74.88%
1.46
Selling General And Administration
2.00
-7.10%
2.16
+853.50%
0.23
-68.51%
0.72
General And Administrative Expense
2.00
-7.10%
2.16
+853.50%
0.23
-68.51%
0.72
Other Gand A
2.00
-7.10%
2.16
+853.50%
0.23
-68.51%
0.72
Total Expenses
5.62
+8.11%
5.20
+87.30%
2.77
+27.52%
2.18
Operating Income
-5.08
-7.05%
-4.75
-83.26%
-2.59
-35.17%
-1.92
Total Operating Income As Reported
-5.08
-7.05%
-4.75
-83.26%
-2.59
-35.17%
-1.92
EBITDA
-5.01
-8.83%
-4.61
-77.99%
-2.59
-39.25%
-1.86
Normalized EBITDA
-5.01
-8.83%
-4.61
-77.99%
-2.59
-39.25%
-1.86
Reconciled Depreciation
0.00
+71.28%
0.00
0.00
—
EBIT
-5.02
-8.86%
-4.61
-78.05%
-2.59
-39.25%
-1.86
Net Income
-5.02
-8.60%
-4.62
-77.81%
-2.60
-39.25%
-1.87
Pretax Income
-5.02
-8.60%
-4.62
-77.81%
-2.60
-39.25%
-1.87
Net Non Operating Interest Income Expense
0.06
-49.38%
0.13
+1700.55%
-0.01
-17.89%
-0.01
Interest Expense Non Operating
0.00
-100.00%
0.01
+12.86%
0.01
+40.65%
0.01
Net Interest Income
0.06
-49.38%
0.13
+1700.55%
-0.01
-17.89%
-0.01
Interest Expense
0.00
-100.00%
0.01
+12.86%
0.01
+40.65%
0.01
Interest Income Non Operating
0.06
-53.37%
0.14
+8114.30%
0.00
+1513.46%
0.00
Interest Income
0.06
-53.37%
0.14
+8114.30%
0.00
+1513.46%
0.00
Other Income Expense
—
—
-0.00
-100.08%
0.06
Other Non Operating Income Expenses
—
—
-0.00
-100.08%
0.06
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-5.02
-8.60%
-4.62
-77.81%
-2.60
-39.25%
-1.87
Net Income From Continuing Operation Net Minority Interest
-5.02
-8.60%
-4.62
-77.81%
-2.60
-39.25%
-1.87
Net Income From Continuing And Discontinued Operation
-5.02
-8.60%
-4.62
-77.81%
-2.60
-39.25%
-1.87
Net Income Continuous Operations
-5.02
-8.60%
-4.62
-77.81%
-2.60
-39.25%
-1.87
Normalized Income
-5.02
-8.60%
-4.62
-77.81%
-2.60
-39.25%
-1.87
Net Income Common Stockholders
-5.02
-8.60%
-4.62
-77.81%
-2.60
-39.25%
-1.87
Diluted EPS
-4.79
+22.24%
-6.16
-20.31%
-5.12
-97.06%
-2.60
Basic EPS
-4.79
+22.24%
-6.16
-20.31%
-5.12
-97.06%
-2.60
Basic Average Shares
1.05
+39.69%
0.75
+47.84%
0.51
-29.31%
0.72
Diluted Average Shares
1.05
+39.69%
0.75
+47.84%
0.51
-29.31%
0.72
Diluted NI Availto Com Stockholders
-5.02
-8.60%
-4.62
-77.81%
-2.60
-39.25%
-1.87
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
2.67
-25.25%
3.58
-39.88%
5.95
+195.60%
2.01
Current Assets
2.62
-23.68%
3.43
-40.87%
5.80
+220.74%
1.81
Cash Cash Equivalents And Short Term Investments
2.18
-33.67%
3.29
-35.69%
5.12
+198.75%
1.71
Cash And Cash Equivalents
2.18
-33.67%
3.29
-35.69%
5.12
+262.26%
1.41
Other Short Term Investments
—
—
0.00
-100.00%
0.30
Receivables
0.08
+162.38%
0.03
-71.59%
0.11
0.00
Other Receivables
0.08
+162.38%
0.03
-71.59%
0.11
—
Prepaid Assets
0.35
+236.71%
0.10
-81.69%
0.56
+501.71%
0.09
Total Non Current Assets
0.06
-61.72%
0.15
-1.94%
0.15
-26.36%
0.20
Net PPE
0.06
-61.72%
0.15
-1.94%
0.15
-26.36%
0.20
Gross PPE
0.19
-32.09%
0.28
-0.45%
0.28
+35.10%
0.20
Accumulated Depreciation
-0.13
-2.26%
-0.13
-1.34%
-0.13
—
Machinery Furniture Equipment
0.14
+0.00%
0.14
+11.47%
0.13
—
Other Properties
0.05
-65.40%
0.14
-10.39%
0.15
-26.36%
0.20
Total Liabilities Net Minority Interest
0.75
+74.34%
0.43
-66.05%
1.27
+116.26%
0.59
Current Liabilities
0.75
+95.77%
0.39
-67.29%
1.18
+245.91%
0.34
Payables And Accrued Expenses
0.71
+138.68%
0.30
-64.95%
0.84
+206.13%
0.28
Payables
0.39
+104.24%
0.19
-50.55%
0.38
+719.52%
0.05
Accounts Payable
0.39
+181.27%
0.14
-64.09%
0.38
+719.52%
0.05
Current Accrued Expenses
0.32
+200.40%
0.11
-76.97%
0.46
+101.04%
0.23
Total Tax Payable
—
0.05
—
—
Current Debt And Capital Lease Obligation
0.05
-46.64%
0.09
-73.23%
0.33
+415.90%
0.06
Current Debt
—
—
0.28
+1000.00%
0.03
Other Current Borrowings
—
—
0.28
+1000.00%
0.03
Current Capital Lease Obligation
0.05
-46.64%
0.09
+53.14%
0.06
+47.13%
0.04
Other Current Liabilities
—
—
0.07
+35.23%
0.05
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
0.05
-50.79%
0.10
-61.30%
0.25
Long Term Debt And Capital Lease Obligation
0.00
-100.00%
0.05
-50.79%
0.10
-55.92%
0.22
Long Term Debt
—
—
—
0.05
Long Term Capital Lease Obligation
0.00
-100.00%
0.05
-50.79%
0.10
-42.83%
0.17
Tradeand Other Payables Non Current
—
—
0.00
-100.00%
0.03
Stockholders Equity
1.92
-38.96%
3.14
-32.75%
4.68
+228.45%
1.42
Common Stock Equity
1.92
-38.96%
3.14
-32.75%
4.68
+228.48%
1.42
Capital Stock
0.00
+105.33%
0.00
-86.93%
0.00
+5.13%
0.00
Common Stock
0.00
+61.33%
0.00
-86.93%
0.00
+48.32%
0.00
Preferred Stock
0.00
0.00
0.00
-100.00%
0.00
Share Issued
1.21
+59.75%
0.76
+5.40%
0.72
+0.00%
0.72
Ordinary Shares Number
1.21
+59.75%
0.76
+5.40%
0.72
+0.00%
0.72
Additional Paid In Capital
17.26
+28.15%
13.47
+29.75%
10.38
+129.13%
4.53
Retained Earnings
-15.34
-48.59%
-10.32
-80.97%
-5.70
-83.60%
-3.11
Total Equity Gross Minority Interest
1.92
-38.96%
3.14
-32.75%
4.68
+228.45%
1.42
Total Capitalization
1.92
-38.96%
3.14
-32.75%
4.68
+217.30%
1.47
Working Capital
1.86
-38.80%
3.04
-34.13%
4.62
+214.90%
1.47
Invested Capital
1.92
-38.96%
3.14
-36.48%
4.95
+230.39%
1.50
Total Debt
0.05
-65.15%
0.14
-68.20%
0.43
+51.79%
0.28
Capital Lease Obligations
0.05
-65.15%
0.14
-11.60%
0.15
-25.70%
0.21
Net Tangible Assets
1.92
-38.96%
3.14
-32.75%
4.68
+228.45%
1.42
Tangible Book Value
1.92
-38.96%
3.14
-32.75%
4.68
+228.48%
1.42
Interest Payable
—
0.00
-100.00%
0.00
-86.90%
0.03
Line Of Credit
—
—
—
0.00
Preferred Stock Equity
0.00
—
—
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-3.95
-25.41%
-3.15
-72.03%
-1.83
-85.10%
-0.99
Cash Flow From Continuing Operating Activities
-3.95
-25.41%
-3.15
-72.03%
-1.83
-85.10%
-0.99
Net Income From Continuing Operations
-5.02
-8.60%
-4.62
-77.81%
-2.60
-39.25%
-1.87
Depreciation Amortization Depletion
0.00
+71.28%
0.00
0.00
—
Depreciation
0.00
+71.28%
0.00
—
—
Depreciation And Amortization
0.00
+71.28%
0.00
0.00
—
Other Non Cash Items
0.20
+65.02%
0.12
+1160.92%
0.01
+40.65%
0.01
Stock Based Compensation
0.75
-44.69%
1.36
+81.30%
0.75
+2.55%
0.73
Operating Gains Losses
—
—
0.75
+1410.30%
-0.06
Gain Loss On Investment Securities
—
—
0.75
+2.55%
0.73
Change In Working Capital
0.11
+1343.25%
-0.01
-195.64%
0.01
-95.18%
0.20
Change In Receivables
—
—
-0.11
-264.63%
0.07
Change In Prepaid Assets
-0.24
-153.06%
0.46
+197.97%
-0.47
-571.10%
-0.07
Change In Payables And Accrued Expense
0.41
+174.82%
-0.55
-192.59%
0.59
+201.30%
0.20
Change In Accrued Expense
0.16
+153.06%
-0.30
-218.47%
0.26
+46.43%
0.17
Change In Payable
0.25
+201.56%
-0.25
-173.00%
0.34
+1409.19%
0.02
Change In Account Payable
0.25
+201.56%
-0.25
-173.00%
0.34
+1409.19%
0.02
Change In Other Working Capital
-0.05
-164.43%
0.08
+171.59%
-0.11
-264.63%
0.07
Change In Other Current Assets
-0.00
+73.37%
-0.00
-518.03%
0.00
-71.43%
0.00
Change In Other Current Liabilities
—
—
0.02
-22.73%
0.02
Investing Cash Flow
0.00
+100.00%
-0.01
-104.80%
0.30
+200.00%
-0.30
Cash Flow From Continuing Investing Activities
0.00
+100.00%
-0.01
-104.80%
0.30
+200.00%
-0.30
Net PPE Purchase And Sale
0.00
+100.00%
-0.01
0.00
—
Purchase Of PPE
0.00
+100.00%
-0.01
0.00
—
Capital Expenditure
—
-0.01
—
—
Net Investment Purchase And Sale
—
0.00
-100.00%
0.30
+200.00%
-0.30
Purchase Of Investment
—
—
—
-0.30
Sale Of Investment
—
0.00
-100.00%
0.30
—
Financing Cash Flow
2.84
+112.62%
1.34
-74.49%
5.24
+149.82%
2.10
Cash Flow From Continuing Financing Activities
2.84
+112.62%
1.34
-74.49%
5.24
+149.82%
2.10
Net Issuance Payments Of Debt
0.00
+100.00%
-0.28
-200.00%
0.28
0.00
Issuance Of Debt
—
0.00
-100.00%
0.28
0.00
Repayment Of Debt
0.00
+100.00%
-0.28
0.00
—
Long Term Debt Issuance
—
0.00
-100.00%
0.28
0.00
Long Term Debt Payments
—
-0.25
0.00
—
Net Long Term Debt Issuance
—
-0.25
-190.91%
0.28
0.00
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
0.00
+100.00%
-0.28
0.00
—
Net Short Term Debt Issuance
0.00
+100.00%
-0.28
0.00
0.00
Net Common Stock Issuance
—
0.00
-100.00%
4.96
+136.71%
2.10
Proceeds From Stock Option Exercised
—
1.61
0.00
—
Changes In Cash
-1.11
+39.34%
-1.83
-149.30%
3.71
+359.42%
0.81
Beginning Cash Position
3.29
-35.69%
5.12
+262.26%
1.41
+133.02%
0.61
End Cash Position
2.18
-33.67%
3.29
-35.69%
5.12
+262.26%
1.41
Free Cash Flow
-3.95
-24.84%
-3.16
-72.82%
-1.83
-85.10%
-0.99
Interest Paid Supplemental Data
0.01
+4.84%
0.01
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
—
0.00
-100.00%
4.96
+136.71%
2.10
Issuance Of Capital Stock
2.84
+76.34%
1.61
-67.53%
4.96
+136.71%
2.10
Net Preferred Stock Issuance
2.84
+76.34%
1.61
—
—
Preferred Stock Issuance
2.84
+76.34%
1.61
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category